Trials / Completed
CompletedNCT01509131
Evaluation of a Mixed Bowel Prep (2L PEG + Bisacodyl) Versus PEG With Ascorbate
Low Volume Bowel Preparation for Colonoscopy: a Comparison Between PEG-CS Plus Bisacodyl Versus PEG-ASC
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 408 (actual)
- Sponsor
- Promefarm S.r.l. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
It is hypothesized that PEG 2L with citrate and simeticone plus bisacodyl will have similar bowel cleansing efficacy versus PEG 2L with ascorbate. Safety, tolerability, acceptance and compliance of the two reduced volume PEG-based bowel preparation will be also compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 2L PEG-CS plus bisacodyl | Patients will be asked to take 2L of Lovolesse and bisacodyl (10-20 mg according to patient bowel habit) |
| DRUG | 2L PEG-ASC | Patients will asked to take PEG-ASC according to labeling instructions |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2012-01-12
- Last updated
- 2012-01-12
Locations
5 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT01509131. Inclusion in this directory is not an endorsement.